Business
Coronavirus vaccine: ‘Unexpected illness’ halts Johnson & Johnson trial – NEWS.com.au
Coronavirus vaccine: ‘Unexpected illness’ halts Johnson & Johnson trial
COVID-19 vaccine clinical trials by Johnson & Johnson in the US have come to a halt after a participant developed an unexplained illness.In a statement, the pharmaceutical giant said further dosing in all COVID-19 candidate vaccine clinical trials had been “temporarily paused”.
This includes phase three of its Janssen Pharmaceutical Companies trial called “Ensemble”, involving up to 60,000 volunteers across three continents.
RELATED: Follow our live coronavirus coverage
“Following our gui…
-
Business24 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend
-
General7 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General22 hours agoFederal government funding extends cohealth GP services until July 2026
-
General10 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique